Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcal Infections | 10 | 2020 | 248 | 3.630 |
Why?
|
| Prenatal Care | 12 | 2025 | 346 | 3.580 |
Why?
|
| Streptococcus agalactiae | 9 | 2020 | 102 | 2.860 |
Why?
|
| Pregnancy Complications, Infectious | 12 | 2023 | 500 | 2.790 |
Why?
|
| Antibiotic Prophylaxis | 6 | 2020 | 121 | 2.260 |
Why?
|
| Pregnancy | 52 | 2025 | 7570 | 1.860 |
Why?
|
| Gynecology | 3 | 2019 | 129 | 1.580 |
Why?
|
| Obstetrics | 4 | 2020 | 246 | 1.560 |
Why?
|
| Chorioamnionitis | 2 | 2021 | 44 | 1.410 |
Why?
|
| Version, Fetal | 2 | 2020 | 5 | 1.340 |
Why?
|
| Infectious Disease Transmission, Vertical | 4 | 2020 | 260 | 1.180 |
Why?
|
| Social Media | 2 | 2022 | 119 | 1.140 |
Why?
|
| Postpartum Hemorrhage | 2 | 2025 | 118 | 1.010 |
Why?
|
| Sepsis | 3 | 2014 | 501 | 0.910 |
Why?
|
| Cesarean Section | 7 | 2023 | 436 | 0.890 |
Why?
|
| Anti-Bacterial Agents | 5 | 2020 | 2565 | 0.870 |
Why?
|
| Periodicals as Topic | 2 | 2019 | 180 | 0.870 |
Why?
|
| Pregnancy Trimester, Third | 4 | 2020 | 126 | 0.830 |
Why?
|
| Female | 59 | 2025 | 71020 | 0.820 |
Why?
|
| Labor Stage, Second | 1 | 2023 | 14 | 0.800 |
Why?
|
| Delphi Technique | 2 | 2024 | 262 | 0.790 |
Why?
|
| Vaginal Birth after Cesarean | 2 | 2020 | 22 | 0.760 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2022 | 31 | 0.730 |
Why?
|
| Surgical Mesh | 1 | 2022 | 61 | 0.730 |
Why?
|
| Endometritis | 1 | 2021 | 9 | 0.730 |
Why?
|
| Neonatal Sepsis | 1 | 2022 | 40 | 0.730 |
Why?
|
| Breech Presentation | 2 | 2020 | 18 | 0.710 |
Why?
|
| Penicillins | 2 | 2020 | 154 | 0.710 |
Why?
|
| Delivery, Obstetric | 4 | 2024 | 259 | 0.700 |
Why?
|
| Humans | 69 | 2025 | 131384 | 0.690 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2023 | 675 | 0.630 |
Why?
|
| Vulvar Lichen Sclerosus | 1 | 2019 | 9 | 0.610 |
Why?
|
| Sexism | 1 | 2019 | 41 | 0.610 |
Why?
|
| Prenatal Diagnosis | 2 | 2018 | 652 | 0.600 |
Why?
|
| Telemedicine | 4 | 2025 | 518 | 0.590 |
Why?
|
| Platelet Count | 1 | 2019 | 140 | 0.590 |
Why?
|
| Genitalia, Female | 1 | 2019 | 49 | 0.590 |
Why?
|
| Cervix Uteri | 2 | 2017 | 59 | 0.590 |
Why?
|
| Lacerations | 1 | 2019 | 32 | 0.580 |
Why?
|
| Drug Hypersensitivity | 1 | 2020 | 97 | 0.580 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2019 | 85 | 0.570 |
Why?
|
| Liability, Legal | 1 | 2018 | 49 | 0.570 |
Why?
|
| Carrier State | 2 | 2015 | 80 | 0.560 |
Why?
|
| Fetal Death | 1 | 2018 | 119 | 0.560 |
Why?
|
| Stillbirth | 1 | 2018 | 103 | 0.540 |
Why?
|
| Patient Preference | 1 | 2019 | 146 | 0.540 |
Why?
|
| Obstetric Labor Complications | 4 | 2024 | 96 | 0.530 |
Why?
|
| Infant, Newborn | 13 | 2023 | 8584 | 0.530 |
Why?
|
| Pandemics | 3 | 2022 | 1159 | 0.520 |
Why?
|
| Betacoronavirus | 1 | 2020 | 287 | 0.510 |
Why?
|
| Parturition | 1 | 2017 | 67 | 0.510 |
Why?
|
| Bias | 1 | 2017 | 144 | 0.490 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 227 | 0.470 |
Why?
|
| Pregnancy Complications | 5 | 2022 | 547 | 0.450 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 366 | 0.450 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 377 | 0.450 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 1251 | 0.430 |
Why?
|
| Pregnancy Outcome | 7 | 2024 | 629 | 0.430 |
Why?
|
| Adult | 25 | 2025 | 31619 | 0.400 |
Why?
|
| Physicians | 1 | 2019 | 634 | 0.390 |
Why?
|
| United States | 9 | 2024 | 11779 | 0.380 |
Why?
|
| Internship and Residency | 1 | 2022 | 1213 | 0.350 |
Why?
|
| Retrospective Studies | 15 | 2025 | 17622 | 0.340 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 3087 | 0.330 |
Why?
|
| Biomedical Research | 1 | 2017 | 556 | 0.330 |
Why?
|
| Cerclage, Cervical | 2 | 2007 | 11 | 0.320 |
Why?
|
| Erythromycin | 2 | 2021 | 19 | 0.300 |
Why?
|
| Postpartum Period | 3 | 2025 | 235 | 0.280 |
Why?
|
| Uterus | 2 | 2007 | 546 | 0.270 |
Why?
|
| Genetic Testing | 1 | 2014 | 1098 | 0.270 |
Why?
|
| Hospitals, Community | 2 | 2007 | 52 | 0.270 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 542 | 0.270 |
Why?
|
| Constriction, Pathologic | 2 | 2007 | 226 | 0.260 |
Why?
|
| Gestational Age | 3 | 2023 | 1220 | 0.260 |
Why?
|
| Hospitals, University | 1 | 2007 | 103 | 0.250 |
Why?
|
| Case-Control Studies | 3 | 2025 | 3448 | 0.250 |
Why?
|
| Parity | 2 | 2024 | 84 | 0.250 |
Why?
|
| Candidiasis, Vulvovaginal | 1 | 2006 | 3 | 0.240 |
Why?
|
| Societies, Medical | 2 | 2021 | 793 | 0.240 |
Why?
|
| Prothrombin Time | 1 | 2006 | 36 | 0.240 |
Why?
|
| Fluconazole | 1 | 2006 | 48 | 0.240 |
Why?
|
| Dilatation and Curettage | 1 | 2025 | 8 | 0.240 |
Why?
|
| Cerebral Palsy | 1 | 2007 | 86 | 0.230 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 1997 | 110 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 3 | 2025 | 1305 | 0.230 |
Why?
|
| Stakeholder Participation | 1 | 2025 | 36 | 0.230 |
Why?
|
| Warfarin | 1 | 2006 | 123 | 0.220 |
Why?
|
| Pelvic Floor | 1 | 2024 | 37 | 0.220 |
Why?
|
| Delivery of Health Care | 4 | 2023 | 682 | 0.210 |
Why?
|
| Consensus | 2 | 2024 | 570 | 0.210 |
Why?
|
| Appointments and Schedules | 1 | 2024 | 49 | 0.210 |
Why?
|
| Vagina | 3 | 2021 | 211 | 0.210 |
Why?
|
| Fetal Viability | 1 | 2023 | 29 | 0.200 |
Why?
|
| Diabetes, Gestational | 1 | 2025 | 111 | 0.200 |
Why?
|
| Antifungal Agents | 1 | 2006 | 298 | 0.200 |
Why?
|
| Decision Making | 2 | 2020 | 681 | 0.200 |
Why?
|
| Labor Stage, First | 1 | 2023 | 8 | 0.200 |
Why?
|
| China | 1 | 2023 | 287 | 0.190 |
Why?
|
| Surgical Instruments | 1 | 2021 | 55 | 0.180 |
Why?
|
| Azithromycin | 1 | 2021 | 45 | 0.180 |
Why?
|
| Maternal Health Services | 1 | 2022 | 48 | 0.180 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2019 | 899 | 0.170 |
Why?
|
| Anticoagulants | 1 | 2006 | 594 | 0.170 |
Why?
|
| Perinatology | 1 | 2021 | 36 | 0.170 |
Why?
|
| Urinary Retention | 1 | 2021 | 18 | 0.170 |
Why?
|
| Overweight | 2 | 2021 | 376 | 0.170 |
Why?
|
| Morbidity | 1 | 2021 | 258 | 0.170 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2021 | 38 | 0.170 |
Why?
|
| Respiratory Insufficiency | 1 | 2023 | 241 | 0.170 |
Why?
|
| Desogestrel | 1 | 2020 | 7 | 0.160 |
Why?
|
| Hysterectomy | 1 | 2022 | 205 | 0.160 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2021 | 68 | 0.160 |
Why?
|
| Point-of-Care Systems | 1 | 2023 | 206 | 0.160 |
Why?
|
| Contraceptive Agents, Female | 1 | 2020 | 32 | 0.160 |
Why?
|
| Simulation Training | 1 | 2022 | 168 | 0.160 |
Why?
|
| Contraception | 1 | 2020 | 62 | 0.150 |
Why?
|
| Uterine Contraction | 2 | 1997 | 29 | 0.150 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2019 | 33 | 0.150 |
Why?
|
| Attitude of Health Personnel | 1 | 2025 | 714 | 0.150 |
Why?
|
| Abortion, Spontaneous | 1 | 2020 | 84 | 0.150 |
Why?
|
| Birth Injuries | 1 | 1999 | 22 | 0.150 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 221 | 0.150 |
Why?
|
| Heart Transplantation | 2 | 2018 | 832 | 0.150 |
Why?
|
| Choice Behavior | 1 | 2019 | 132 | 0.140 |
Why?
|
| Heart Rate, Fetal | 1 | 2018 | 64 | 0.140 |
Why?
|
| Maternal Age | 1 | 2018 | 137 | 0.140 |
Why?
|
| Twins | 2 | 2014 | 71 | 0.140 |
Why?
|
| Pregnancy, Multiple | 2 | 2014 | 44 | 0.140 |
Why?
|
| Probability | 1 | 2018 | 310 | 0.140 |
Why?
|
| Dilatation | 3 | 2024 | 70 | 0.140 |
Why?
|
| Endometriosis | 1 | 2021 | 185 | 0.140 |
Why?
|
| Nausea | 1 | 2018 | 83 | 0.140 |
Why?
|
| Prospective Studies | 5 | 2021 | 6479 | 0.140 |
Why?
|
| Reference Values | 1 | 2019 | 691 | 0.140 |
Why?
|
| Anesthesia | 1 | 2020 | 208 | 0.130 |
Why?
|
| Middle Aged | 5 | 2021 | 28800 | 0.130 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 179 | 0.130 |
Why?
|
| Rectus Abdominis | 1 | 1997 | 10 | 0.130 |
Why?
|
| Vomiting | 1 | 2018 | 104 | 0.130 |
Why?
|
| Abruptio Placentae | 1 | 1997 | 14 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2022 | 3112 | 0.130 |
Why?
|
| Heart Diseases | 2 | 2019 | 505 | 0.130 |
Why?
|
| Treatment Outcome | 3 | 2022 | 12915 | 0.130 |
Why?
|
| Heart-Assist Devices | 2 | 2018 | 991 | 0.130 |
Why?
|
| Dystocia | 1 | 1997 | 25 | 0.130 |
Why?
|
| Robotic Surgical Procedures | 1 | 2021 | 235 | 0.130 |
Why?
|
| Hematoma | 1 | 1997 | 90 | 0.120 |
Why?
|
| Terbutaline | 1 | 1996 | 7 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2020 | 423 | 0.120 |
Why?
|
| Muscular Diseases | 1 | 1997 | 118 | 0.120 |
Why?
|
| Tocolytic Agents | 1 | 1996 | 11 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 643 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 458 | 0.120 |
Why?
|
| Odds Ratio | 2 | 2015 | 1235 | 0.120 |
Why?
|
| Chlamydia trachomatis | 1 | 1995 | 30 | 0.120 |
Why?
|
| Coronary Aneurysm | 1 | 1996 | 31 | 0.120 |
Why?
|
| Gastroplasty | 1 | 1995 | 12 | 0.120 |
Why?
|
| Obstetric Labor, Premature | 1 | 1996 | 77 | 0.120 |
Why?
|
| Chlamydia Infections | 1 | 1995 | 53 | 0.120 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 1996 | 50 | 0.120 |
Why?
|
| Amoxicillin | 1 | 1995 | 118 | 0.110 |
Why?
|
| Thromboembolism | 1 | 1995 | 86 | 0.110 |
Why?
|
| Term Birth | 1 | 2014 | 35 | 0.110 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1994 | 30 | 0.110 |
Why?
|
| Recurrence | 2 | 2015 | 1476 | 0.110 |
Why?
|
| Texas | 3 | 2013 | 3614 | 0.110 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1994 | 114 | 0.110 |
Why?
|
| Aneuploidy | 1 | 2014 | 141 | 0.100 |
Why?
|
| Quality of Life | 1 | 2024 | 2103 | 0.100 |
Why?
|
| Young Adult | 4 | 2024 | 10080 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1995 | 224 | 0.100 |
Why?
|
| Fibrinolytic Agents | 1 | 1995 | 200 | 0.100 |
Why?
|
| Labor, Obstetric | 1 | 2013 | 99 | 0.100 |
Why?
|
| Catheterization, Central Venous | 1 | 1994 | 140 | 0.100 |
Why?
|
| Forecasting | 1 | 2014 | 361 | 0.100 |
Why?
|
| Time Factors | 3 | 2018 | 6272 | 0.100 |
Why?
|
| Risk Factors | 3 | 2021 | 10943 | 0.090 |
Why?
|
| Bacteriological Techniques | 1 | 2013 | 86 | 0.090 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 4030 | 0.090 |
Why?
|
| Age Factors | 1 | 2019 | 2869 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 741 | 0.090 |
Why?
|
| Michigan | 2 | 2022 | 47 | 0.090 |
Why?
|
| Heart Failure, Systolic | 1 | 2012 | 34 | 0.090 |
Why?
|
| Heart Atria | 1 | 1994 | 336 | 0.090 |
Why?
|
| Influenza Vaccines | 1 | 2016 | 500 | 0.090 |
Why?
|
| Vaccination | 1 | 2016 | 1039 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2016 | 703 | 0.080 |
Why?
|
| Thrombosis | 1 | 1994 | 494 | 0.080 |
Why?
|
| Mass Screening | 1 | 2015 | 825 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1404 | 0.080 |
Why?
|
| Incidence | 2 | 2013 | 3339 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2024 | 970 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 1996 | 998 | 0.070 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 87 | 0.070 |
Why?
|
| Cervical Length Measurement | 1 | 2007 | 5 | 0.070 |
Why?
|
| Male | 6 | 2019 | 65101 | 0.070 |
Why?
|
| Aged | 3 | 2022 | 21209 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2007 | 1907 | 0.070 |
Why?
|
| Uterine Cervical Incompetence | 1 | 2007 | 5 | 0.070 |
Why?
|
| Elective Surgical Procedures | 1 | 2007 | 157 | 0.060 |
Why?
|
| Heart Failure | 1 | 2018 | 2306 | 0.060 |
Why?
|
| Glucose Tolerance Test | 1 | 2025 | 200 | 0.050 |
Why?
|
| Focus Groups | 1 | 2025 | 227 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2021 | 1682 | 0.050 |
Why?
|
| Patient Selection | 1 | 2007 | 723 | 0.050 |
Why?
|
| Adolescent | 2 | 2019 | 20899 | 0.050 |
Why?
|
| Patient Outcome Assessment | 1 | 2023 | 92 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2023 | 5118 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2025 | 700 | 0.040 |
Why?
|
| Prevalence | 1 | 2008 | 2692 | 0.040 |
Why?
|
| Pelvic Pain | 1 | 2021 | 27 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2025 | 1102 | 0.040 |
Why?
|
| Curettage | 1 | 2020 | 6 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2021 | 147 | 0.040 |
Why?
|
| Drug Implants | 1 | 2020 | 41 | 0.040 |
Why?
|
| Puerperal Disorders | 1 | 2020 | 50 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2020 | 52 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2024 | 1450 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2021 | 352 | 0.040 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 162 | 0.040 |
Why?
|
| Birth Weight | 1 | 2021 | 346 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 694 | 0.040 |
Why?
|
| Obesity | 2 | 2021 | 2376 | 0.040 |
Why?
|
| Weight Gain | 1 | 2021 | 383 | 0.040 |
Why?
|
| Abdomen, Acute | 1 | 1997 | 13 | 0.030 |
Why?
|
| Counseling | 1 | 2019 | 237 | 0.030 |
Why?
|
| Trial of Labor | 1 | 1997 | 22 | 0.030 |
Why?
|
| Device Removal | 1 | 2018 | 222 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1997 | 271 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 470 | 0.030 |
Why?
|
| Contraindications | 1 | 1996 | 77 | 0.030 |
Why?
|
| Self Report | 1 | 2019 | 558 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2021 | 1006 | 0.030 |
Why?
|
| Arginine | 1 | 2018 | 343 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 1831 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 1223 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1995 | 82 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2025 | 1409 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 1995 | 132 | 0.030 |
Why?
|
| Cesarean Section, Repeat | 1 | 1994 | 12 | 0.030 |
Why?
|
| History, 20th Century | 1 | 1995 | 366 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 1995 | 206 | 0.020 |
Why?
|
| Rectum | 1 | 2013 | 102 | 0.020 |
Why?
|
| Reoperation | 1 | 1995 | 835 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 3691 | 0.020 |
Why?
|
| Hemorrhage | 1 | 1995 | 498 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1995 | 1137 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2013 | 427 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2012 | 242 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3832 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2012 | 608 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2018 | 15036 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 1076 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 2140 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 2145 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2982 | 0.010 |
Why?
|
| Child | 2 | 2018 | 26220 | 0.010 |
Why?
|
| Premature Birth | 1 | 2007 | 415 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 13291 | 0.010 |
Why?
|